Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia

被引:0
|
作者
Ben-Hamadi, R
Duh, MS
Aggarwal, J
Henckler, A
McKenzie, S
Fastenau, J
Piech, CT
机构
[1] Anal Grp Inc, Boston, MA USA
[2] Ortho Biotech Clin Affairs LLC, Dallas, TX USA
[3] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
关键词
D O I
10.1016/S1098-3015(10)62574-0
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:238 / 238
页数:1
相关论文
共 50 条
  • [21] Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia
    Cersosimo, RJ
    Jacobson, DR
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (01) : 58 - 65
  • [22] COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
    Lafeuille, M. H.
    Bailey, R. A.
    Senbetta, M.
    McKenzie, R. S.
    Lefebvre, P.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
  • [23] Comparing the cost-effectiveness of front loaded darbepoetin alfa with epoetin alfa for anemia management in chemotherapy-treated cancer patients in United States
    Glaspy, J
    Tchekmedyian, N
    Gupta, S
    VALUE IN HEALTH, 2002, 5 (06) : 538 - 538
  • [24] Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: The 20030125 study group trial
    Glaspy, John
    Vadhan-Raj, Saroj
    Patel, Ravi
    Bosserman, Linda
    Hu, Eddie
    Lloyd, Richard E.
    Boccia, Ralph V.
    Tomita, Dianne
    Rossi, Greg
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2290 - 2297
  • [25] Rapid correction of anemia with darbepoetin alfa once every 3 weeks in chemotherapy-induced anemia
    Grangeia, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 384 - 385
  • [26] Once-weekly epoetin alfa for treating the anemia of chronic kidney disease
    Provenzano, R
    Garcia-Mayol, L
    Suchinda, P
    Von Hartitzsch, B
    Woollen, SB
    Zabaneh, R
    Fink, JC
    CLINICAL NEPHROLOGY, 2004, 61 (06) : 392 - 405
  • [27] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [28] A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer
    Schwartzberg, LS
    Yee, LK
    Senecal, FM
    Charu, V
    Tomita, D
    Wallace, J
    Rossi, G
    ONCOLOGIST, 2004, 9 (06): : 696 - 707
  • [29] Prevention of anemia by early intervention with once weekly epoetin alfa during chemotherapy
    Codrington, H.
    Schouwink, J. H.
    Sleeboom, H. P.
    Kerkhofs, L. G. M.
    Wormhoudt, L. W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 148 - 148
  • [30] Clinical benefits and risks associated with darbepoetin alfa and epoetin alfa treatment in patients with lung cancer and chemotherapy-induced anemia.
    Tiotiu, Angelica
    Clerc-Urmes, Isabelle
    Chabot, Francois
    Martinet, Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)